97 related articles for article (PubMed ID: 7871389)
1. In vivo evidence for a non-T cell origin of interleukin-5.
Castro AG; Silva RA; Minóprio P; Appelberg R
Scand J Immunol; 1995 Mar; 41(3):288-92. PubMed ID: 7871389
[TBL] [Abstract][Full Text] [Related]
2. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection.
Appelberg R; Castro AG; Pedrosa J; Silva RA; Orme IM; Minóprio P
Infect Immun; 1994 Sep; 62(9):3962-71. PubMed ID: 8063414
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of granuloma formation in murine Mycobacterium avium infection: the contribution of CD4+ T cells.
Hänsch HC; Smith DA; Mielke ME; Hahn H; Bancroft GJ; Ehlers S
Int Immunol; 1996 Aug; 8(8):1299-310. PubMed ID: 8918699
[TBL] [Abstract][Full Text] [Related]
4. IL-12 promotes drug-induced clearance of Mycobacterium avium infection in mice.
Doherty TM; Sher A
J Immunol; 1998 Jun; 160(11):5428-35. PubMed ID: 9605144
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil-derived IFN-gamma induces airway hyperresponsiveness and lung inflammation in the absence of lymphocytes.
Kanda A; Driss V; Hornez N; Abdallah M; Roumier T; Abboud G; Legrand F; Staumont-Sallé D; Quéant S; Bertout J; Fleury S; Rémy P; Papin JP; Julia V; Capron M; Dombrowicz D
J Allergy Clin Immunol; 2009 Sep; 124(3):573-82, 582.e1-9. PubMed ID: 19539982
[TBL] [Abstract][Full Text] [Related]
6. The cytolytic activity of natural killer cells is not involved in the restriction of Mycobacterium avium growth.
Flórido M; Correia-Neves M; Cooper AM; Appelberg R
Int Immunol; 2003 Aug; 15(8):895-901. PubMed ID: 12882827
[TBL] [Abstract][Full Text] [Related]
7. The relative impact of bacterial virulence and host genetic background on cytokine expression during Mycobacterium avium infection of mice.
Castro AG; Minóprio P; Appelberg R
Immunology; 1995 Aug; 85(4):556-61. PubMed ID: 7558149
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-12 primes CD4+ T cells for interferon-gamma production and protective immunity during Mycobacterium avium infection.
Silva RA; Flórido M; Appelberg R
Immunology; 2001 Jul; 103(3):368-74. PubMed ID: 11454066
[TBL] [Abstract][Full Text] [Related]
9. The role of tumor necrosis factor, interferon-gamma, transforming growth factor-beta, and nitric oxide in the expression of immunosuppressive functions of splenic macrophages induced by Mycobacterium avium complex infection.
Tomioka H; Sato K; Maw WW; Saito H
J Leukoc Biol; 1995 Dec; 58(6):704-12. PubMed ID: 7499969
[TBL] [Abstract][Full Text] [Related]
10. Endogenously produced IL-12 is required for the induction of protective T cells during Mycobacterium avium infections in mice.
Castro AG; Silva RA; Appelberg R
J Immunol; 1995 Aug; 155(4):2013-9. PubMed ID: 7636252
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium avium infection in mice is associated with time-related expression of Th1 and Th2 CD4+ T-lymphocyte response.
Azouaou N; Petrofsky M; Young LS; Bermudez LE
Immunology; 1997 Jul; 91(3):414-20. PubMed ID: 9301531
[TBL] [Abstract][Full Text] [Related]
12. T-cell-independent granuloma formation in response to Mycobacterium avium: role of tumour necrosis factor-alpha and interferon-gamma.
Smith D; Hänsch H; Bancroft G; Ehlers S
Immunology; 1997 Dec; 92(4):413-21. PubMed ID: 9497481
[TBL] [Abstract][Full Text] [Related]
13. The role of tumour necrosis factor-alpha in combination with interferon-gamma or interleukin-1 in the induction of immunosuppressive macrophages because of Mycobacterium avium complex infection.
Tomioka H; Maw WW; Sato K; Saito H
Immunology; 1996 May; 88(1):61-7. PubMed ID: 8707352
[TBL] [Abstract][Full Text] [Related]
14. Exposure to Mycobacterium avium decreases the protective effect of the DNA vaccine pVAXhsp65 against Mycobacterium tuberculosis-induced inflammation of the pulmonary parenchyma.
Martins DR; Pelizon AC; Zorzella-Pezavento SF; Seger J; Santos Junior RR; Fonseca DM; Justulin LA; Silva CL; Sartori A
Scand J Immunol; 2011 Apr; 73(4):293-300. PubMed ID: 21214611
[TBL] [Abstract][Full Text] [Related]
15. Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection.
Doherty TM; Sher A
J Immunol; 1997 May; 158(10):4822-31. PubMed ID: 9144497
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of IL-12 in immunotherapy and vaccine design in experimental Mycobacterium avium infections.
Silva RA; Pais TF; Appelberg R
J Immunol; 1998 Nov; 161(10):5578-85. PubMed ID: 9820535
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterium avium infection of macrophages results in progressive suppression of interleukin-12 production in vitro and in vivo.
Wagner D; Sangari FJ; Kim S; Petrofsky M; Bermudez LE
J Leukoc Biol; 2002 Jan; 71(1):80-8. PubMed ID: 11781383
[TBL] [Abstract][Full Text] [Related]
18. Modulation by IL-10 of antigen-induced IL-5 generation, and CD4+ T lymphocyte and eosinophil infiltration into the mouse peritoneal cavity.
Zuany-Amorim C; Créminon C; Nevers MC; Nahori MA; Vargaftig BB; Pretolani M
J Immunol; 1996 Jul; 157(1):377-84. PubMed ID: 8683140
[TBL] [Abstract][Full Text] [Related]
19. Lactic dehydrogenase virus infection inhibits allergic eosinophil reaction and IL-5 gene expression in vivo.
Morimoto M; Iwata H; Hayashi T
Int Arch Allergy Immunol; 1999 Sep; 120(1):78-84. PubMed ID: 10529592
[TBL] [Abstract][Full Text] [Related]
20. Identification of R146225 as a novel, orally active inhibitor of interleukin-5 biosynthesis.
Van Wauwe J; Aerts F; Cools M; Deroose F; Freyne E; Goossens J; Hermans B; Lacrampe J; Van Genechten H; Van Gerven F; Van Nyen G
J Pharmacol Exp Ther; 2000 Nov; 295(2):655-61. PubMed ID: 11046102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
